First to the future of cardiac PET
David R. Langston, SBN #11923800
Brad W. Odell, SBN #24065839
Mullin Hoard & Brown, LLP
P.O. Box 2585
Lubbock, TX 79408
Tel: 806-765-7491
Fax: 806-765-0553
www.mullinhoard.com
Attorneys for Positron Corporation
IN THE UNITED STATES BANKRUPTCY COURT
FOR THE... Read More
CHICAGO, IL, - April 7, 2015 (PRNewswire) -- Positron Corporation (OTCBB:POSC), a nuclear medicine healthcare company (“Positron” or the “Company”), today announced the approval of its reverse stock split of Positron common stock on a 1-for-400 basis. The Company anticipates the split will be effective on April 8,... Read More
CHICAGO, IL January 20, 2015 (PRNewswire) – Positron Corporation (OTCBB:POSC) is pleased to announce that the United States Patent and Trademark Office (USPTO) has awarded the Institute for Nuclear Research (INR) of the Russian Academy of Sciences a patent (U.S. No. 8,929,503) for the method for producing... Read More
CHICAGO, IL – November 14, 2013 (PRNewswire) – Positron Corporation (OTCBB:POSC)(the “Company”), a nuclear medicine healthcare company, is pleased to announce the appointment of Joseph G. Oliverio as its President. Mr. Oliverio will direct the Company’s cardiac PET mission and oversee Positron’s PET technology,... Read More
CHICAGO, IL – October 11, 2013 (PRNewswire) – Positron Corporation (OTCBB:POSC) is proud to announce its wholly owned subsidiary, Manhattan Isotope Technology, has received ISO 9001 certification for the production of radioisotopes. ISO is the International Organization for Standardization. The ISO 9001... Read More
CHICAGO, IL – September 26, 2013 (PRNewswire) – Positron Corporation (OTCBB:POSC) is pleased to announce it has entered into a licensing agreement with the Institute for Nuclear Research of the Russian Academy of Science (INR), Moscow, Russia, for its know-how, inventions and technology related to the production of... Read More
